Suite 300 — Washington D.C., District of Columbia

Suite 300 is a clinical research site located in Washington D.C., District of Columbia, United States 20006.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Suite 300 has participated in 1 clinical trials.

Therapeutic areas: Arthritis, Rheumatoid.

Sponsors: Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Suite 300?

Suite 300 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Suite 300 conducted?

Suite 300 has 1 clinical trials on record. Their work covers Arthritis, Rheumatoid.

Is Suite 300 accredited by Crixeo Health?

Suite 300 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Suite 300?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.